Latest News
Lunai Bioworks and Geneial enter into LOI to build rare disease patient cohorts for drug development partnerships
15 April 2026 - AI-driven drug discovery company Lunai Bioworks Inc (NASDAQ: LNAI) reported on Wednesday that it has entered into a non-binding Letter of Intent through its BioSymetrics subsidiary with precision medicine data infrastructure company G...
QT Imaging Debuts QT Imaging-Olea Viewer for integrated multimodality breast imaging
15 April 2026 - Medical device company QT Imaging Holdings Inc (Nasdaq:QTI) announced on Wednesday the launch of the QT Imaging-Olea Viewer, developed in collaboration with Olea Medical, a leader in advanced imaging software solutions.The viewer prov...
Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology
15 April 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) announced on Wednesday that it has entered into an evaluation agreement with Canadian biotechnology company Acuitas Therapeutics to assess in vivo CAR-T cell therapy applications.The...
GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma
15 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) reported on Wednesday that it has completed the acquisition of 35Pharma Inc, a Canada-based clinical-stage biopharmaceutical company focused on protein-based therapeutics. The d...
Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential
15 April 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) announced on Wednesday that it has received Clinical Trial Authorisation from the UK Medicines and Healthcare products Regulatory Agency for its POLB 001 TOPICAL trial, with int...